Cases were notified of their SARS2(+) results at a median of 1 day (range 1–4) after swab collection, at which time 1/9 (95% CI 0.01, 46) was in the pre-symptomatic phase (notified 2 days after swab collected), a second had mild symptoms mis-attributed to “allergies” (notified 4 four days after swab collected), while the remaining seven had sought testing due to COVID-19 symptoms. The gene discussed is SARS2; the disease is Allergy.